SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Category: Latest News

    FDA Approves First Biosimilar Drug for Treatment of Wet AMD

    Posted on November 29, 2021November 29, 2021 by Dan Roberts
  • November 29, 2021

    FDA Approves First Biosimilar Drug for Treatment of Wet AMD

    The U.S. Food and Drug Administration (FDA) has approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of wet AMD. Byooviz is also approved to treat macular edema and myopic choroidal neovascularization, a vision-threatening complication of myopia (nearsightedness). The drug is administered by intravitreal injection (delivered into the vitreous humor […]

      Also posted in
    • Latest News
    • Therapies, Treatments, and Procedures
  • FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

    Posted on October 22, 2021April 2, 2022 by Dan Roberts
  • October 22, 2021

    FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

    Susvimo, previously called Port Delivery System with ranibizumab, is the first wet AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month. By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with wet AMD maintain their vision with as […]

      Also posted in
    • Latest News
    • Therapies, Treatments, and Procedures
  • Port Delivery System Under Priority Review by FDA

    Posted on June 24, 2021April 2, 2022 by Dan Roberts
  • June 24, 2021

    Port Delivery System Under Priority Review by FDA

    Frequent Eye Injections May Soon Be History Genentech Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) is giving priority review for the company’s Port Delivery System for the treatment of wet age-related macular degeneration (AMD). If approved, PDS will be a first-of-its-kind therapeutic approach, offering people living with wet AMD an alternative […]

      Also posted in
    • Latest News
    • Research and Developments
  • Rising Above COVID19 Depression

    Posted on June 20, 2021June 20, 2021 by Dan Roberts
  • June 20, 2021

    Rising Above COVID19 Depression

    Prevalence of all forms of depression during the COVID19 pandemic was found to be 20% in a study population of 113,285 individuals.(1) Not unexpectedly, this is higher than the pre-pandemic rate. Compounded with already high levels of depression among those who are socially isolated due to visual impairment (2), this gives cause for increased concern […]

      Also posted in
    • Daily Living
    • Latest News
    • Low Vision Rehabilitation
  • Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

    Posted on June 11, 2021June 13, 2021 by Dan Roberts
  • June 11, 2021

    Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

    Several studies have identified specific nutrients and healthy behaviors as effective in delaying the development and slowing the progression of age-related diseases like macular degeneration. It has been said that the best cure for age-related macular degeneration (AMD) is to simply stop growing older. Now a pilot study of 43 men ages 50 to 72 […]

      Also posted in
    • Health and Nutrition
    • Latest News
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 68
  • Next Page »
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.